Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

WORD

HTML

975

Figures (1-7)

108

Sum=1116

Publishing Process of This Article

Item

Count

Browse

Download

189

Sum=263

Nov 16, 2023 (publication date) through May 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Nov 16, 2023; 11(32): 7911-7919
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7911

Full Size Figure Download Figure

Figure 5 Timeline of Case 2’s clinical management and outcome. SDSC: SMARCB1-deficient sinonasal carcinomas.

Citation: Zhang L, Gao AX, He YL, Xu MJ, Lu HJ. Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports. World J Clin Cases 2023; 11(32): 7911-7919
URL: https://www.wjgnet.com/2307-8960/full/v11/i32/7911.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i32.7911